Evidence map›Paper›PMID 40427765›Full record

ArticleBiology2025

Unveiling Prophage Diversity and Host Interactions in Liberibacter: Genomic Insights for Phage Therapy Against Citrus Huanglongbing.

Hui Yin, Jiaxing Wan, Siyu Zhang, Zhuozhuo Wu, Wanshan Zhang, Yuxia Gao

Abstract read
In one paragraph

Article in Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hui YinNational Navel Orange Engineering Research Center, Gannan Normal University, Ganzhou 341000, China.
Jiaxing WanNational Navel Orange Engineering Research Center, Gannan Normal University, Ganzhou 341000, China.
Siyu ZhangNational Navel Orange Engineering Research Center, Gannan Normal University, Ganzhou 341000, China.
Zhuozhuo WuNational Navel Orange Engineering Research Center, Gannan Normal University, Ganzhou 341000, China.
Wanshan ZhangNational Navel Orange Engineering Research Center, Gannan Normal University, Ganzhou 341000, China.
Yuxia GaoNational Navel Orange Engineering Research Center, Gannan Normal University, Ganzhou 341000, China.ORCID 0000-0002-6237-365X

Funding

Double Thousand Plan of Jiangxi Province jxsq2020102134
6 · The paper itself

Abstract

HLB is a severe and devastating disease affecting citrus plants, for which no cure is currently available. The pathogen CLas is an unculturable, phloem-limited α-proteobacterium associated with HLB. Phages, known for their ability to directly lyse pathogenic bacteria, have been widely recognized as effective control agents in both medical and agricultural fields. In this study, we identified 191 prophages across 48 Liberibacter genomes using comparative genomics and phylogenetic methods. These prophages were classified into 17 distinct types, with 13 novel types, named NF1 to NF13. Diversity analysis revealed that the number of prophages per genome ranged from one to eight, with an average of four. Annotation showed that the genome sizes of NF1-NF13 ranged from 10,160 bp to 72,736 bp, with an average size of 27,616 bp, containing between 7 and 66 genes (average: 27 genes). Further functional enrichment of the sequences within 5 kb upstream and downstream of the integration site identified six main aspects, involving four core biological processes: genome structure modification, gene expression regulation, stress response activation, and metabolic pathway modulation. It is speculated that the insertion of the prophage significantly impacts the host. Six virulence factors, including

Indexed as

diversityHuanglongbingprophagevirulence factors

Identifiers

PMID40427765
PMCPMC12109144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.